CD79A and cancer: Several pathways like intestinal immune network for IgA production and primary immunodeficiency were associated with the low-risk group, while ECM-receptor interaction, focal adhesion, pathways in cancer and TGF-β signaling pathway were found in the high-risk group (Figures 5E, F).